Modern aspects of diagnostic and surgical treatment of patients with hip periprosthetic infection (review)

Cover Page


Cite item

Full Text

Abstract

Hip replacement is widespread surgical procedure in orthopedic surgery. Nether the less, the main and most costly problems in replacement of large joints with socially significant losses are infectious complications. The aim of this review is to analyze available data dedicated to infectious complications in orthopedy and to extract basic principles of diagnostics and treatment of the hip joint implant infection. It could be stated that early diagnostics and precise identification of causative agent, including evaluation of the microbiological, clinical, diagnostic imaging, immunological, histological and biochemical parameters, and also an adequate to the collected diagnostic data choice of surgical tactics and antibiotic treatment are the important components of successful treatment of periprosthetic infection.

About the authors

V. V. Pavlov

Tsivyan Novosibirsk Research Institute of Traumatology and Ortopaedics

Author for correspondence.
Email: pavlovdoc@mail.ru
Russian Federation

M. A. Sadovoy

Tsivian Novosibirsk Scientific Research Institute of Traumatology and Ortopaedics

Email: noemail@neicon.ru
Russian Federation

V. M. Prokhorenko

Tsivian Novosibirsk Scientific Research Institute of Traumatology and Ortopaedics

Email: noemail@neicon.ru
Russian Federation

References

  1. Божкова С.А, Петрова Т.М., Мирзоев Н.Э. Этиологическая структура и антибиотикорезистентность ведущих возбудителей парапротезной инфекции в стационаре травматолого-ортопедического профиля. В кн.: Рациональная фармакотерапия и клиническая фармакология: сборник научных материалов Конгресса. СПб.; 2010. С. 49-52.
  2. Гольдина И.А., Павлов В.В., Прохоренко В.М. Клинико-морфологические особенности коксартроза, ассоциированного с Chlamydia Trachomatis. Бюллетень СО РАМН. 2007; (124):43-46.
  3. Материалы международной согласительной конференции по перипротезной инфекции: пер. с англ. под общ. ред. Р.М. Тихилова. СПб.; 2014. 355 с.
  4. Пат. 2204832 РФ. МПК, G01N33/48 Способ прогнозирования риска развития инфекционных осложнений. Павлов В.В., Гольдина И.А., Прохоренко В.М., Гайдуль К.В., Козлов В.А., Фомичев Н.Г. Заявитель и патентообладатель ФГБУ НИИТО им. Я.Л. Цивьяна. (RU) № 2001104752, заявлен 19.02.2001; опубликован 20.05. 2003. Бюлл. № 14.
  5. Пичхадзе И.М., Жадин А.В., Кузьменков K.A., Цискаришвили А.В., Данелия Л.М. Лечение больных с гнойно-воспалительными осложнениями после эндопротезирования тазобедренного сустава. Вестн. травматологии и ортопедии им. Н.Н. Приорова. 2009; (3):45-50.
  6. Прохоренко В.М., Павлов В.В. Инфекционные осложнения при эндопротезировании тазобедренного сустава. Новосибирск: Наука; 2010. 179 с.
  7. Савельев В.С. Российские национальные рекомендации по классификации характера инфекции по уровням поражения. Под ред. В.С. Савельева. М.; 2009. 92 с.
  8. Фадеев С.Б. Хирургическая инфекция мягких тканей второго уровня, особенности этиотропной терапии [автореф. дис. д.м.н.]. Оренбург; 2010.
  9. Ata A., Lee J., Bestle S.L., Desemone J., Stain S.C. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg. 2010; 145(9): 858-864. doi: 10.1001/archsurg.2010.179.
  10. Berbari E.F., Osmon D.R., Carr A., Hanssen A.D., Baddour L.M., Greene D. et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin. Infect. Dis. 2010; 50(1):8-16. doi: 10.1086/648676.
  11. Bergh C., Fenstad A.M., Furnes O., Garellick G., Havelin L.I., Overgaard S. et al. Increased risk of revision in patients with non-traumatic femoral head necrosis. Acta Orthop. 2014; 85(1):11-7. doi: 10.3109/17453674.2013.874927.
  12. Bogut A., Niedzwiadek J., Strzelec-Nowak D., Blacha J., Mazurkiewicz T., Marczynski W., Koziol-Montewka M. Infectious prosthetic hip joint loosening: bacterial species involved in its aetiology and their antibiotic resistance profiles against antibiotics recommended for the therapy of implant-associated infections. New Microbiol. 2014; 37(2):209-218.
  13. Bourne R.B., Hunter G.A., Rorabeck C.H., Macnab J.J. A six year follow-up infected total hip arthroplasty managed by Girdlestone’s arthroplasty. J Bone Joint Surg. 1996; 66-B:340-343.
  14. Buechel F.F., Femino F.P., D'Alessio J. Primary exchange revision arthroplasty for infected total knee replacement: a long-term study. Am J Orthop. 2004; 33:190.
  15. Cazanave C., Greenwood-Quaintance K.E., Hanssen A.D., Karau M.J., Schmidt S.M., Gomez Urena E.O. et al. Rapid molecular microbiologic diagnosis of prosthetic joint infection. J Clin Microbiol. 2013; 51(7):2280-2287. doi: 10.1128/JCM.00335-13.
  16. Coelho-Prabhu N., Oxentenko A.S., Osmon D.R., Baron T.H., Hanssen A.D., Wilson W.R. et al. Increased risk of prosthetic joint infection associated with esophago-gastroduodenoscopy with biopsy. Acta Orthop. 2013;84(1): 82-86. doi: 10.3109/17453674.2013.769079.
  17. Coventry M.B. Treatment of infections occurring in total hip surgery. Orthop Clin North Am. 1975; 6(4): 991-1003.
  18. Crockarell J.R., Hanssen A.D., Osmon D.R., Morrey B.F Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg. 1998; 80-A:1306-1313.
  19. Deirmengian C., Kardos K., Kilmartin P., Cameron A., Schiller K., Parvizi J. Combined measurement of synovial fluid α-defensin and C-reactive protein levels: highly accurate for diagnosing periprosthetic joint infection. J Bone Joint Surg Am. 2014;96(17): 1439-1445. doi: 10.2106/JBJS.M.01316.
  20. Deleanu B., Prejbeanu R., Vermesan D., Haragus H., Icma I., Predescu V. Acute abdominal complications following hip surgery. Chirurgia (Bucur). 2014; 109(2):218-222.
  21. Della Valle C., Parvizi J., Bauer T.W., Di Cesare P.E. Evans R.P Segreti J. et al. Diagnosis of periprosthetic joint infections of the hip and knee. J AAOS. 2010; 18(12):760-770.
  22. Drago L., Vassena C., Dozio E., Corsi M.M., De Vecchi E., Mattina R., Romano C. Procalcitonin, C-reactive protein, interleukin-6, and soluble intercellular adhesion molecule-1 as markers of postoperative orthopaedic joint prosthesis infections. Int J Immunopathol Pharmacol. 2011; 24(2):433-440.
  23. Drancourt M., Stein A., Argenson J.N., Zannier A., Curvale G., Raoult D. Oral rifampicin plus ofloxacin for treatment of Staphylococcus - infected orthopaedic implants. Antimicrob Agents Chemother. 1993; 37:305-313.
  24. El Masri F., Kerboull L., Kerboull M., Courpied J.P., Hamadouche M. Is the so-called 'French paradox' a reality?: long-term survival and migration of the Charnley-Kerboull stem cemented line-to-line. J Bone Joint Surg Br. 2010; 92(3):342-348.
  25. Fevang B.T., Lie S.A., Havelin L.I., Engesaeter L.B., Furnes O. Improved results of primary total hip replacement. Acta Orthop. 2010; 81(6):649-659.
  26. Fitzgerald M.D., Robert H. Infected total hip arthroplasty: diagnosis and treatment. J. AAOS. 1995; (3):249-262.
  27. Gollwitzer H., Diehl P., Gerdesmeyer L., Mittelmeier W. Diagnostic strategies in cases of suspected periprosthetic infection of the knee. A review of the literature and current recommendations. Orthopedics. 2006; 35(9):904, 906-908, 910-916.
  28. Glehr M., Friesenbichler J., Hofmann G., Bernhardt G.A., Zacherl M., Avian A. et al. Novel biomarkers to detect infection in revision hip and knee arthroplasties. Clin Orthop Relat Res. 2013; 471(8): 2621-2628. doi: 10.1007/ s11999-013-2998-3.
  29. Greidanus N.V., Masri B.A., Garbuz D.S., Wilson S.D., McAlinden M.G., Xu M., Duncan C.P Use of erythrocyte sedimentation rate and C-reactive protein level to diagnose infection before revision total knee arthroplasty: a prospective evaluation. J Bone Joint Surg Am. 2007; 89-A:1409-1416.
  30. Gutowski C.J., Zmistowski B.M., Clyde C.T., Parvizi J. The economics of using prophylactic antibiotic-loaded bone cement in total knee replacement. Bone Joint J. 2014; 96-B(1):65-69. doi: 10.1302/0301-620X.96B1.31428.
  31. Haddad F.S., Masri B.A., Campbell D., McGraw R.W., Beuchamp C.P., Duncan C.P. The PROSTALAC functional spacer in two-stage revision for infected knee replacements. prosthesis of antibiotic-loaded acrylic cement. J Bone Joint Surg. 2000; 82-B:807-812.
  32. Hailer N.P., Garellick G., Karrholm J. Uncemented and cemented primary total hip arthroplasty in the Swedish Hip Arthroplasty Register. Acta Orthop. 2010; 81(1): 34-41.
  33. Horan T.C., Gaynes R.P., Martone W.J., Jarvis W.R., Emori T.G. CDC definitions of nosocomial surgical site infections, 1992; A modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992; 13:606-608.
  34. Jonsson E.Ö., Johannesdottir H., Robertsson O., Mogensen B. Bacterial contamination of the wound during primary total hip and knee replacement. Median 13 years of follow-up of 90 replacements. Acta Orthop. 2014; 85(2):159-164. doi: 10.3109/17453674.2014.899848.
  35. Jordan R.W., Smith N.A., Saithna A., Sprowson A.P., Foguet P. Sensitivities, specificities, and predictive values of microbiological culture techniques for the diagnosis of prosthetic joint infection. Biomed Res Int. 2014; 2014:180416. doi: 10.1155/2014/180416.
  36. Kraay M.J., Goldberg V.M., Fitzgerald S.J., Salata M.J. Cementless two-staged total hip arthroplasty for deep periprosthetic infection. Clin Orthop. 2005; 441:243-249.
  37. Kundu Z.S., Gupta V., Gogna P., Sangwan S.S. Partial-limb salvage after persistent infection in the distal femoral prosthesis: straight-plasty - a novel technique. J Coll Physicians Surg Pak. 2014; 24(3):213-215. doi: 03.2014/ JCPSP213215.
  38. Leaper D., McBain A.J., Kramer A., Assadian O., Sanchez J.L., Lumio J., Kiernan M. Healthcare associated infection: novel strategies and antimicrobial implants to prevent surgical site infection. Ann R Coll Surg Engl. 2010; 92(6):453-458. doi: 10.1308/003588410X12699663905276.
  39. Mäkelä K.T., Matilainen M., Pulkkinen P., Fenstad A.M., Havelin L.I., Engesaeter L. et al. Countrywise results of total hip replacement. An analysis of 438,733 hips based on the Nordic Arthroplasty Register Association database. Acta Orthop. 2014;(85()) 107-116. doi: 10.3109/17453674.2014.893498.
  40. Miyamae Y., Inaba Y., Kobayashi N., Choe H., Yukizawa Y., Ike H., Saito T. Different diagnostic properties of C-reactive protein, real-time PCR, and histopathology of frozen and permanent sections in diagnosis of periprosthetic joint infection. Acta Orthop. 2013;84(6):524-529. doi: 10.3109/17453674.2013.862460.
  41. Lachiewictz P.F., Rogers G.D., Thomason H.C. Aspiration of the joint before revision total hip arthroplasty: clinical and laboratory factors influencing attainment of a positive culture. J Bone Joint Surg Am. 1996; 78(5):749-754.
  42. Larsen L.H., Lange J., Xu Y., Schonheyder H.C. Optimizing culture methods for diagnosis of prosthetic joint infections: a summary of modifications and improvements reported since 1995. J Med Microbiol. 2012; 61(Pt 3):309-316. doi: 10.1099/jmm.0.035303-0.
  43. Parvizi J., Jacovides C., Antoci V., Ghanem E. Diagnosis of periprosthetic joint infection: the utility of a simple yet unappreciated enzyme. J Bone Joint Surg Am. 2011; 93(24):2242-2248. doi: 10.2106/JBJS.J.01413.
  44. Parvizi J., Jacovides C., Zmistowski B., Jung K.A. Definition of periprosthetic joint infection: Is there a consensus? Clin Orthop Relat Res. 2011; 469(11):3022-3030.
  45. Pearson O.M., Lieberman D.E. The aging of Wolffs “law” ontogeny and responses to mechanical loading in cortical bone. Am J Phys Anthropol. 2004; Suppl. 39:63-99.
  46. Peel T.N., Dowsey M.M., Daffy J.R., Stanley P.A., Choong P.F., Buising K.L. Risk factors for prosthetic hip and knee infections according to arthroplasty site. J Hosp Infect. 2011; 79(2):129-133. doi: 10.1016/j.jhin.2011.06.001.
  47. Pedersen A.B., Svendsson J.E., Johnsen S.P., Riis A., Overgaard S. Risk factors for revision due to infection after primary total hip arthroplasty. A population-based study of 80,756 primary procedures in the Danish Hip Arthroplasty Registry. Acta Orthop. 2010; 81(5):542-547.
  48. Phillips C.B. Incidence rates of dislocation, pulmonary embolism and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg. 2003; 85-A (1):20-26.
  49. Prokopetz J.Z., Losina E., Bliss R.L., Wright J., Baron J.A., Katz J.N. Risk factors for revision of primary total hip arthroplasty: a systematic review. BMC Musculoskelet Disord. 2012; 13:251. doi: 10.1186/1471-2474-13-251.
  50. Reid N., Beesley J.E. Sectioning and cryosectioning for electron microscopy. Amsterdam: Elsevier; 1991. 322p.
  51. Ravi B., Escott B., Shah P.S., Jenkinson R., Chahal J., Bogoch E., Kreder H., Hawker G. A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis Rheum. 2012; 64(12):3839-3849. doi: 10.1002/art.37690.
  52. Saccente M. Periprosthetic joint infections: a review for clinicians. Infect Dis Clin Pract. 1998; (7):431-441.
  53. Schamalzried T.P., Amstutz H.C., Au M.K. Etiology of deep sepsis in total hip arthroplasty: the significance of hematogenous and recurrent infections. Clin Orthop Relat Res. 1992; 280: 200-207.
  54. Schwotzer N., Wahl P., Fracheboud D., Gautier E., Chuard C. Optimal culture incubation time in orthopedic deviceassociated infections: a retrospective analysis of prolonged 14-day incubation. J Clin Microbiol. 2014; 52(1):61-66. doi: 10.1128/JCM.01766-13.
  55. Schrama J.C., Espehaug B., Hallan G., Engesaeter L.B., Furnes O., Havelin L.I., Fevang B.T. Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register. Arthritis Care Res. (Hoboken). 2010; 62(4):473-479.
  56. Siebel T., Kelm J., Porsch M., Regitz T., Neumann W.H. Two-stage exchange of infected knee arthroplasty with an prosthesis-like interim cement spacer. Acta Orthop Belg. 2002; 68:150-156.
  57. Sonohata M., Kitajima M., Kawano S., Mawatari M. Acute hematogenous infection of revision total hip arthroplasty by oral bacteria in a patient without a history of dental procedures: case report. Open Orthop J. 2014; 8:56-59. doi: 10.2174/1874325001408010056.
  58. Spangehl M.J., Masri B.A., O’Connell J.X. Prospective analysis of preoperative and intraoperative investigations for diagnosis of infection at the sites of two hundred and two revision total hip arthroplasty. J Bone Joint Surg Am. 1999; 81(5): 672-683.
  59. Squire M.W., Della Valle C.J., Parvizi J. Preoperative diagnosis of periprosthetic joint infection: Role of aspiration. AJR. 2011; 196:875-879.
  60. Tsukayama D.T., Estrada R., Gustilo R.B. Infection after total hip arthroplasty: a study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996; 78(4):512-523.
  61. Waldman B.J., Hostin E., Mont M.A., Hunfergord D.S. Infected total knee arthroplasty treated by arthroscopic irrigation and debridement. J Arthropl. 2000; 15: 430-436.
  62. Wu C., Qu X., Liu F., Li H., Mao Y., Zhu Z. Risk factors for periprosthetic joint infection after total hip arthroplasty and total knee arthroplasty in Chinese patients. PLoS One. 2014; 9(4):e95300. doi: 10.1371/journal.pone.0095300.
  63. Zimmerli W., Trampuz A. Ochsner P.E. Prosthetic joint infections. NEJM. 2004; 351:1645-1654.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 82474 от 10.12.2021.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies